Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers.

Min S, Song I, Borland J, Chen S, Lou Y, Fujiwara T, Piscitelli SC.

Antimicrob Agents Chemother. 2010 Jan;54(1):254-8. doi: 10.1128/AAC.00842-09. Epub 2009 Nov 2.

PMID:
19884365
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
[PubMed - indexed for MEDLINE]
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
[PubMed - indexed for MEDLINE]
4.

Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir.

Cottrell ML, Hadzic T, Kashuba AD.

Clin Pharmacokinet. 2013 Nov;52(11):981-94. doi: 10.1007/s40262-013-0093-2. Review.

PMID:
23824675
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges.

Lenz JC, Rockstroh JK.

Expert Opin Investig Drugs. 2011 Apr;20(4):537-48. doi: 10.1517/13543784.2011.562189. Epub 2011 Mar 8. Review.

PMID:
21381981
[PubMed - indexed for MEDLINE]
6.

Dolutegravir: an exciting new kid on the block.

Blanco Arévalo JL, Whitlock GG.

Expert Opin Pharmacother. 2014 Mar;15(4):573-82. doi: 10.1517/14656566.2014.868883. Epub 2014 Jan 22. Review.

PMID:
24446762
[PubMed - indexed for MEDLINE]
7.

Tolerability of HIV integrase inhibitors.

Lee FJ, Carr A.

Curr Opin HIV AIDS. 2012 Sep;7(5):422-8. doi: 10.1097/COH.0b013e328356682a. Review.

PMID:
22886031
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk